Literature DB >> 31128051

De-escalating systemic chemotherapy might be considered for pure triple negative apocrine breast cancer patients.

Kadri Altundag1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31128051

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


× No keyword cloud information.
  1 in total

1.  Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.

Authors:  Wenyu Wu; Meiying Wu; Guowen Peng; Degang Shi; Jian Zhang
Journal:  Cancer Med       Date:  2019-10-23       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.